Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and Cancer Pain

angiotensin ii, des-phe(8)- has been researched along with Cancer Pain in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Alabsi, W; Hay, M; Largent-Milnes, TM; Polt, R; Sulaiman, MI; Szabo, L; Vanderah, TW1
Arnold, MR; Forte, BL; Hay, M; Largent-Milnes, TM; Slosky, LM; Staatz, WD; Vanderah, TW; Zhang, H1

Other Studies

2 other study(ies) available for angiotensin ii, des-phe(8)- and Cancer Pain

ArticleYear
PNA6, a Lactosyl Analogue of Angiotensin-(1-7), Reverses Pain Induced in Murine Models of Inflammation, Chemotherapy-Induced Peripheral Neuropathy, and Metastatic Bone Disease.
    International journal of molecular sciences, 2023, Oct-09, Volume: 24, Issue:19

    Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cancer Pain; Disease Models, Animal; Female; Humans; Hyperalgesia; Mice; Mice, Inbred C57BL; Neuralgia; Oxaliplatin

2023
Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain.
    Pain, 2016, Volume: 157, Issue:12

    Topics: Analgesics; Analysis of Variance; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Bone Neoplasms; Cancer Pain; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hyperalgesia; Imidazoles; Losartan; Mice; Mice, Inbred BALB C; Nesting Behavior; Peptide Fragments; Pyridines; Rotarod Performance Test

2016